{"member_organisations": "Albanian Hemophilia Association(294), \nArmenian Association Hemophilics(228), \n\u00d6sterreichischen H\u00e4mophilie Gesellschaft (\u00d6HG)(717), \nAzerbaijan Republic Association of Haemophilia (ARAH)(1400), \nBelarusian Association Hemophilia(800), \nBelgian Haemophilia Society(3000), \nHemophilia Association of Bosnia & Herzegovina(50), \nBulgarian Haemophilia Association(730), \nCroatian Hemophilia Society(50), \nPancyprian Organization for Rehabilitation of Haemophiliacs(10), \nCzech Haemophilia Society(1500), \nDanmarks Bl\u00f8derforening(800), \nEesti Hemofiiliauhing(50), \nFinish Hemophilia Society(3500), \nAssociation Francaise des H\u00e9mophiles(7500), \nGeorgian Association of Hemophilia and Donors(300), \nDeutsche H\u00e4mophilie Gesellschaft (DHG)(9000), \nGreek Haemophilia Society(2000), \nMagyar Hemofilia Egyesulet(200), \nIcelandic Haemophilia Society(50), \nIrish Haemophilia Society(2500), \nIsraeli Hemophilia Association(600), \nFederazione delle Associazioni Emofilici(8000), \nCommunity of Handicapped - Hemophiliacs in Kyrgyz Republic (350), \nLatvijas Hemofilijas Biedr\u012bba(250), \nLietuvos Hemofiljos Associja(450), \nAssociation Luxembourgeoise des H\u00e9mophiles(25), \nBleeding Disorder Society Hemolog(300), \nMoldavian Public Society of Haemophilie(230), \nMontenegrin Association for Hemophilia(20), \nNederlandse Vereniging van Hemofilie-Pati\u00ebnten (NVHP)(3000), \nNorwegian Haemophilia Society(1500), \nPolish Hemophilia Society(4000), \nAssocia\u00e7\u00e3o Portuguesa de Hemofilia(700), \nRomanian Hemophilia Association(2000), \nRussian Hemophilia Society(8000), \nSerbian Hemophilia Society(250), \nSlovensk\u00e9 hemofilick\u00e9 zdru\u017eenie(500), \nDrustvo Hemofilikov Slovenije(2000), \nFederaci\u00f3n Espa\u00f1ola de Hemofilia(3000), \nSwedish Hemophilia Society(3000), \nSchweizerische H\u00e4mophilie-Gesellschaft (SHG)(1000), \nHemophilia Society of Turkey(8000), \nUkrainian Hemophilia Union(3000), \nThe Haemophilia Society(23000)", "identification_number": "786550013705-85", "fields_of_interest": "Public Health", "head_office_address": "Rue de l'Industrie 10", "full_time_equivalent_fte": "5", "person_with_legal_responsibility": "Amanda Bok", "financial_year_start_date": "01/01/2016", "grants": "", "country_code": "BE", "head_office_country": "Belgium", "eu_initiatives": "Clinical Trial Regulation, Orphan Medicinal Product Regulation, Cross-Border Healthcare Directive, Blood Directive, Transparency Directive, Public Procurement Directive", "level_of_interest": "European, national", "organisation_name": "European Haemophilia Consortium (EHC)", "belgium_office_post_code": "", "procurement": "", "section": "III - Non-governmental organisations", "lon": 4.369373, "source": "", "belgium_office_address": "", "belgium_office_phone": "", "number_of_ep_accredited_persons": "6", "overall_budget_turnover_as_a_range": "", "subsection": "Non-governmental organisations, platforms and networks and similar", "no_geo_reference": true, "persons_accredited_for_access_to_european_parliament_premises": "BOK#Fay Amanda, EERENS#Johan, Jansone#Kristine, Mihaylova#Raia, Pfeyffer#Saskia, SAVINI#Laura", "estimate_of_costs_absolute_amount": "", "registration_date": "27/05/2014", "website_address": "http://www.ehc.eu", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Bruseels", "membership": "Eurordis \nEuropean Patients' Forum (EPF)", "head_office_post_code": "1000", "goals__remit": "The European Haemophilia Consortium (EHC) is an international non-profit organisation that represents 45 national patient organisations of people with rare bleeding disorders from 27 Member States of the European Union (EU) and most Member States of the Council of Europe. \n \nThe EHC represents over 90,000 people diagnosed with a rare bleeding condition such as haemophilia, von Willebrand Disease and other rare bleeding disorders across Europe. However, it is estimated that many more live with an undiagnosed rare bleeding disorder.   \n \nThe EHC's main external objectives are to: \n \n1) Support and empower National Member Organisations (NMOs) at national and European levels, and help them to engage with each other;  \n \n2) Promote access to optimal treatment and comprehensive care for people with rare bleeding disorders in Europe;  \n \n3) Ensure constructive engagement with key stakeholders; and  \n \n4) Work pro-actively in and contribute to European policy-making for rare bleeding disorders. \n \n \n\u2003", "industry_forums": "", "inter_groups": "", "number_of_persons_involved": "6", "relevant_communication": "Round Tables of Stakeholders, advocacy campaigns, representation with the European Commission, European Parliament and European Medicines Agency", "financial_year_end_date": "01/12/2016", "lat": 50.841755, "estimate_of_costs_as_a_range": "200000-299999", "overall_budget_turnover_absolute_amount": "1529521", "legal_status": "AISBL", "person_in_charge_of_eu_relations": "Amanda Bok", "customers": "", "belgium_office_post_box": "", "position": "CEO", "belgium_office_city": "", "head_office_phone": "(+32)2 8932470"}